MBIOTECH.ORG - Site Information

エム バイオ テック株式会社　ホームページ マイコプラズマ肺炎の早期診断が切望されているが、マイコプラズマ脂質抗原を用いることにより従来の診断薬よりはるかに特異的で高感度な診断がそれを可能とした。 Early diagnosis of Mycoplasma pneumoniae-infection has been eager to be established, and specific and sensitive diagnostic method using Mycoplasma pneumoniae lipid-antigen made it possible. 自己免疫疾患・リウマチ性疾患・喘息・神経疾患の原因として、マイコプラズマという微生物が原因であるという報告が多くある。しかし、信頼のできる診断法がなく、臨床的に確定することが難しかった。当社は、上記の難治性疾患と関連の深い、マイコプラズマ・ニューモニエおよびマイコプラズマ・ファーメンタンスの主要脂質抗原の構造解析・化学合成に成功した。この技術を基盤として、臨床診断・治療の実用化に向けて開発を進めている。 Mycoplasmas have been reported as pathogens of autoimmune diseases, rheumatic diseases, athma, ALS, multiple screrosis, so on. However, it was difficult to fix the pathogenesis, because there were not reliable diagnostic tools to identify or detect them. We have succeeded to determine the structures of the specific lipid-antigens and succeeded to synthesize them. Based on these technology, we developed diagnostic tools.? Mbiotech.org

To improve performance of SITEINFO service and to prevent its excessive high-volume use by a single source, we implemented a randomly generated Access Code that must be entered before running a SITEINFO request.

The Access Code in the box is provided in graphics format. It has letters which are generated randomly and the symbol images are distorted. The distorted symbols cannot be read by computer programs which are used for mass-collect email addresses and any customer information. Only humans can read the distorted symbols and pass the access code. The Access Code improves performance of our services. It prevents excessive high-volume use by a single source.

The services that require Access Codes are: